FDA approved Furoscix ReadyFlow, the first autoinjector delivering IV-equivalent furosemide for adults with heart failure or chronic kidney disease. The device enables rapid, at-home treatment of edema, with commercial launch expected by August 2026.

Original document:

This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.